Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1469090 | 0.81 | MEN1 (0.47) | MEN1KMT2ATDP1 | |
| SCHEMBL1930793 | 0.75 | MEN1 (0.36) | MEN1KMT2ATDP1 | |
| SCHEMBL5480450 | 0.75 | MEN1 (0.36) | MEN1KMT2ATDP1 | |
| SCHEMBL11064209 | 0.74 | MEN1 (0.39) | MEN1KMT2ATDP1 | |
| SCHEMBL11061148 | 0.74 | MEN1 (0.39) | MEN1KMT2ATDP1 | |
| SCHEMBL11060948 | 0.69 | MEN1 (0.50) | MEN1KMT2ATDP1 | |
| Perflunafene SCHEMBL1069193 | 0.69 | MEN1 (1.00) | MEN1KMT2ATDP1 | |
| SCHEMBL15755574 | 0.69 | MEN1 (1.00) | MEN1KMT2ATDP1 | |
| Perflunafene SCHEMBL63606 | 0.69 | MEN1 (1.00) | MEN1KMT2ATDP1 | |
| SCHEMBL2476658 | 0.69 | MEN1 (1.00) | MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9138398-B2 | Cationic alcohols and uses thereof | LIVING PROOF, INC. (US) | 2015-09-22 | — | — | US | disclosed |
| US-20130156719-A1 | CATIONIC ALCOHOLS AND USES THEREOF | LIVING PROOF, INC. (US) | 2013-06-20 | — | — | US | disclosed |
| US-8404221-B2 | Cationic alcohols and uses thereof | LIVING PROOF, INC. (US) | 2013-03-26 | — | — | US | disclosed |
| US-20120276036-A1 | CATIONIC ALCOHOLS AND USES THEREOF | LIVING PROOF, INC. (US) | 2012-11-01 | — | — | US | disclosed |
| US-8242309-B2 | Cationic alcohols and uses thereof | LIVING PROOF, INC. (US) | 2012-08-14 | — | — | US | disclosed |
| US-20110070179-A1 | CATIONIC ALCOHOLS AND USES THEREOF | LIVING PROOF, INC. (US) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130156719-A1 | CATIONIC ALCOHOLS AND USES THEREOF | ADH1A, ADH1C, TRPV1 | MEN1 1891/4885KMT2A 1279/4885TDP1 2561/4885 |
| US-20120276036-A1 | CATIONIC ALCOHOLS AND USES THEREOF | ADH1A, ADH1C, TRPV1 | MEN1 1891/4885KMT2A 1279/4885TDP1 2561/4885 |
| US-20110070179-A1 | CATIONIC ALCOHOLS AND USES THEREOF | ADH1A, ADH1C, TRPV1 | MEN1 1891/4885KMT2A 1279/4885TDP1 2561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.